Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 First Quarter Financial Results

[PR Newswire] – THE WOODLANDS, Texas, May 8, 2014 /PRNewswire/ — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated … more

View todays social media effects on LXRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Lexicon is hiring next, click here to view